Publicacions en què col·labora amb Elena Ramírez García (11)

2023

  1. Editorial: Reducing the harm of medication–recent trends in pharmacovigilance (volume II)

    Frontiers in Pharmacology

2022

  1. Editorial: Reducing the Harm of Medication–Recent Trends in Pharmacovigilance

    Frontiers in Pharmacology

  2. LTT and HLA testing as diagnostic tools in Spanish vancomycin-induced DRESS cases: A case-control study

    Frontiers in Pharmacology, Vol. 13

2020

  1. Assessment of drug causality in Stevens-Johnson syndrome/toxic epidermal necrolysis: Concordance between lymphocyte transformation test and ALDEN

    Allergy: European Journal of Allergy and Clinical Immunology

  2. HLA-A∗68, -A∗11:01, and -A∗29:02 alleles are strongly associated with benznidazole-induced maculopapular exanthema (MPE)/DRESS

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 8, Núm. 9, pp. 3198-3200.e3

2019

  1. Incidence of Stevens-Johnson syndrome/toxic epidermal necrolysis among new users of different individual drugs in a European population: a case-population study

    European Journal of Clinical Pharmacology, Vol. 75, Núm. 2, pp. 237-246

2018

  1. Active surveillance of severe cutaneous adverse reactions: A case-population approach using a registry and a health care database

    Pharmacoepidemiology and Drug Safety, Vol. 27, Núm. 9, pp. 1042-1050

2017

  1. Approach to Severe Cutaneous Adverse Drug Reactions

    Current Treatment Options in Allergy, Vol. 4, Núm. 2, pp. 201-221

  2. Cyclosporine Use in Epidermal Necrolysis Is Associated with an Important Mortality Reduction: Evidence from Three Different Approaches

    Journal of Investigative Dermatology, Vol. 137, Núm. 10, pp. 2092-2100

  3. Significant HLA class I type associations with aromatic antiepileptic drug (AED)-induced SJS/TEN are different from those found for the same AED-induced DRESS in the Spanish population

    Pharmacological Research, Vol. 115, pp. 168-178

2016

  1. The HLA-B∗15:02 allele in a Spanish Romani patient with carbamazepine-induced Stevens-Johnson syndrome

    Pharmacogenomics, Vol. 17, Núm. 6, pp. 541-545